Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MS Patient, Ph.D.: The Doctors of Oz
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
MS Patient, Ph.D.: Neuroradiology Reader Roulette
Papers: 13 Nov 2015 - 20 Nov 2015
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
MRI monitoring of spinal cord changes in patients with multiple sclerosis.
MRI in multiple sclerosis: what's inside the toolbox?
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.
Papers: 13 Sep 2013 - 20 Sep 2013
MS Research Roundup: February 26, 2014
Epidemiology of Multiple Sclerosis in Latin America: Critical Analysis of the Literature.
Papers: 14 Nov 2014 - 21 Nov 2014
Disability as an outcome in MS clinical trials.
Papers: 28 Feb 2016 - 6 Mar 2016
Papers: 10 Jul 2015 - 17 Jul 2015
Papers: 5 Jun 2015 - 12 Jun 2015
Evidence Grows for Pathogenic Antibody
Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy.
Papers: 28 Mar 2016 - 4 Apr 2016
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients.
A GWAS Gets Into Shape
Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
Papers: 12 Jun 2015 - 19 Jun 2015
Papers: 19 Jun 2015 - 26 Jun 2015
Pages
« first
‹ previous
…
25
26
27
28
29
30
31
32
33
…
next ›
last »
